"Frontrunner of Phase II - IV clinical trials in New York City since 2001, Private Research Clinic"

During the past decade, Fieve Clinical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 11 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fieve Clinical Research" #1 sponsor was "Pfizer" with 5 trials, followed by "Cephalon" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

According to Clinical.Site data, the most researched conditions in "Fieve Clinical Research" are "Depressive Disorder, Major" (6 trials), "Generalized Anxiety Disorder" (2 trials), "Major Depressive Disorder" (2 trials), "Migraine" (2 trials) and "Migraine, With or Without Aura" (2 trials). Many other conditions were trialed in "Fieve Clinical Research" in a lesser frequency.

Most popular intervention types in "Fieve Clinical Research" are "Drug" (21 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Rapastinel" (3 trials), "Aticaprant" (2 trials), "Gabitril" (2 trials) and "Rimegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fieve Clinical Research" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fieve Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Fieve Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fieve Clinical Research, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".